Publication Name	World Journal of Gastroenterology
Manuscript ID	18474
Country	Japan

Received	2015-04-21 15:30
Peer-Review Started	2015-04-22 18:29
To Make the First Decision	2015-06-02 15:21
Return for Revision	2015-06-08 11:37
Revised	2015-06-17 00:00
Second Decision	2015-08-19 14:47
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2015-09-02 15:10
Articles in Press	2015-09-02 15:10
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2015-09-11 10:02
Publish the Manuscript Online	2015-09-28 18:06

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access	Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Topic Highlights
Article Title	Sub-classification of intermediate-stage (Barcelona Clinic Liver Cancer stage-B) hepatocellular carcinomas
Manuscript Source	Invited Manuscript
All Author List	Koichiro Yamakado and Shozo Hirota
Funding Agency and Grant Number
Corresponding Author	Koichiro Yamakado, MD, Department of Radiology, Hyogo College of Medicine, 1-1 Mukogawa, Nishinomiya, Hyogo 663-8501, Japan. yama@clin.medic.mie-u.ac.jp
Key Words	Hepatocellular carcinoma; Intermediate-stage; Chemoembolization; Child-Pugh score; Prognosis
Core Tip	There are movements to divide the intermediate stage of hepatocellular carcinoma (HCC) because of the diversity of intermediate-stage patients. This review describes two substaging systems (Bolondi substaging system and substaging system proposed by Japanese Society of Transcatheter Hepatic Arterial Embolization) that subclassify intermediate-stage HCCs and discusses the importance of dividing intermediate-stage patients.
Publish Date	2015-09-28 18:06
Citation	Yamakado K, Hirota S. Sub-classification of intermediate-stage (Barcelona Clinic Liver Cancer stage-B) hepatocellular carcinomas. World J Gastroenterol 2015; 21(37): 10604-10608
URL	http://www.wjgnet.com/1007-9327/full/v21/i37/10604.htm
DOI	http://dx.doi.org/10.3748/wjg.v21.i37.10604

Full Article (PDF)	WJG-21-10604.pdf
Full Article (Word)	WJG-21-10604.doc
Manuscript File	18474-Review.doc
Answering Reviewers	18474-Answering reviewers.pdf
Audio Core Tip	18474-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	18474-Conflict-of-interest statement.pdf
Copyright License Agreement	18474-Copyright assignment.pdf
Peer-review Report	18474-Peer-review(s).pdf
Scientific Misconduct Check	18474-Scientific misconduct check.pdf
Scientific Editor Work List	18474-Scientific editor work list.pdf